Innovating Works

CHANPHARM GMBH

Desconocido
TOX-Free: TOXicity assessment on neurons and cardiomyocytes by means of FluoRescence Emitting Electrodes CHANPHARM GMBH participó en un H2020: H2020-FETOPEN-2018-2020 Pre- and post-marketing data on drug side effects show that neurotoxicity and cardiotoxicity are frequently missed or underestimated during...
2020-12-16 - 2024-11-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.